Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.

Allen CT, Lee S, Norberg SM, Kovalovsky D, Ye H, Clavijo PE, Hu-Lieskovan S, Schlegel R, Schlom J, Strauss J, Gulley JL, Trepel J, Hinrichs CS.

J Immunother Cancer. 2019 May 3;7(1):119. doi: 10.1186/s40425-019-0603-3.

2.

How patients with an intact immune system develop head and neck cancer.

Greene S, Patel P, Allen CT.

Oral Oncol. 2019 May;92:26-32. doi: 10.1016/j.oraloncology.2019.03.010. Epub 2019 Mar 18. Review.

PMID:
31010619
3.

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.

Sun L, Clavijo PE, Robbins Y, Patel P, Friedman J, Greene S, Das R, Silvin C, Van Waes C, Horn LA, Schlom J, Palena C, Maeda D, Zebala J, Allen CT.

JCI Insight. 2019 Apr 4;4(7). pii: 126853. doi: 10.1172/jci.insight.126853. eCollection 2019 Apr 4.

4.

Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function.

Clavijo PE, Friedman J, Robbins Y, Moore EC, Smith E, Zauderer M, Evans EE, Allen CT.

Cancer Immunol Res. 2019 Feb;7(2):282-291. doi: 10.1158/2326-6066.CIR-18-0156. Epub 2018 Dec 4.

PMID:
30514791
5.

Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer.

Xiao R, Allen CT, Tran L, Patel P, Park SJ, Chen Z, Van Waes C, Schmitt NC.

Oncoimmunology. 2018 Aug 1;7(9):e1471440. doi: 10.1080/2162402X.2018.1471440. eCollection 2018.

6.

Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types.

Hicks KC, Fantini M, Donahue RN, Schwab A, Knudson KM, Tritsch SR, Jochems C, Clavijo PE, Allen CT, Hodge JW, Tsang KY, Schlom J, Gameiro SR.

Oncoimmunology. 2018 Jul 30;7(11):e1466018. doi: 10.1080/2162402X.2018.1466018. eCollection 2018.

7.

WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy.

Sun L, Moore E, Berman R, Clavijo PE, Saleh A, Chen Z, Van Waes C, Davies J, Friedman J, Allen CT.

Oncoimmunology. 2018 Jul 23;7(10):e1488359. doi: 10.1080/2162402X.2018.1488359. eCollection 2018.

8.

Examining Men's Perceptions of GBV Prevention Programming Content.

Allen CT, Carlson J, Casey EA, Tolman RM, Leek C.

Violence Against Women. 2019 Apr;25(5):614-632. doi: 10.1177/1077801218796324. Epub 2018 Sep 24.

PMID:
30246617
9.

Left Ventricular Decompression Using a Percutaneous Transvalvular Microaxial Ventricular Assist Device in Patients Receiving VA ECMO.

Allen CT, Litton E.

J Cardiothorac Vasc Anesth. 2019 May;33(5):1479-1480. doi: 10.1053/j.jvca.2018.08.020. Epub 2018 Aug 16. No abstract available.

PMID:
30228052
10.

Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.

Friedman J, Morisada M, Sun L, Moore EC, Padget M, Hodge JW, Schlom J, Gameiro SR, Allen CT.

J Immunother Cancer. 2018 Jun 21;6(1):59. doi: 10.1186/s40425-018-0374-2.

11.

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms.

Moore EC, Sun L, Clavijo PE, Friedman J, Harford JB, Saleh AD, Van Waes C, Chang EH, Allen CT.

Oncoimmunology. 2018 May 7;7(7):e1404216. doi: 10.1080/2162402X.2017.1404216. eCollection 2018. Erratum in: Oncoimmunology. 2018 Dec 13;8(2):e1534569.

12.

Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma.

Zolkind P, Przybylski D, Marjanovic N, Nguyen L, Lin T, Johanns T, Alexandrov A, Zhou L, Allen CT, Miceli AP, Schreiber RD, Artyomov M, Dunn GP, Uppaluri R.

Oncotarget. 2017 Dec 28;9(3):4109-4119. doi: 10.18632/oncotarget.23751. eCollection 2018 Jan 9.

13.

PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation.

Morisada M, Clavijo PE, Moore E, Sun L, Chamberlin M, Van Waes C, Hodge JW, Mitchell JB, Friedman J, Allen CT.

Oncoimmunology. 2017 Nov 27;7(3):e1395996. doi: 10.1080/2162402X.2017.1395996. eCollection 2018.

14.

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma.

Tran L, Allen CT, Xiao R, Moore E, Davis R, Park SJ, Spielbauer K, Van Waes C, Schmitt NC.

Cancer Immunol Res. 2017 Dec;5(12):1141-1151. doi: 10.1158/2326-6066.CIR-17-0235. Epub 2017 Nov 2.

15.

The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosis.

Ahn J, Bishop JA, Roden RBS, Allen CT, Best SRA.

Laryngoscope. 2018 Jan;128(1):E27-E32. doi: 10.1002/lary.26847. Epub 2017 Sep 22.

16.

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells.

Clavijo PE, Moore EC, Chen J, Davis RJ, Friedman J, Kim Y, Van Waes C, Chen Z, Allen CT.

Oncotarget. 2017 Jun 11;8(34):55804-55820. doi: 10.18632/oncotarget.18437. eCollection 2017 Aug 22.

17.

Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer.

Morisada M, Moore EC, Hodge R, Friedman J, Cash HA, Hodge JW, Mitchell JB, Allen CT.

Oral Oncol. 2017 Aug;71:87-94. doi: 10.1016/j.oraloncology.2017.06.005. Epub 2017 Jun 10.

18.

Susceptibility to Ebbinghaus and Müller-Lyer illusions in autistic children: a comparison of three different methods.

Manning C, Morgan MJ, Allen CTW, Pellicano E.

Mol Autism. 2017 Mar 23;8:16. doi: 10.1186/s13229-017-0127-y. eCollection 2017.

19.

Murray secretion scale and fiberoptic endoscopic evaluation of swallowing in predicting aspiration in dysphagic patients.

Kuo CW, Allen CT, Huang CC, Lee CJ.

Eur Arch Otorhinolaryngol. 2017 Jun;274(6):2513-2519. doi: 10.1007/s00405-017-4522-y. Epub 2017 Mar 12.

PMID:
28286927
20.

Getting men in the room: perceptions of effective strategies to initiate men's involvement in gender-based violence prevention in a global sample.

Casey EA, Leek C, Tolman RM, Allen CT, Carlson JM.

Cult Health Sex. 2017 Sep;19(9):979-995. doi: 10.1080/13691058.2017.1281438. Epub 2017 Feb 21.

PMID:
28276920
21.

Evaluating the utility of serological testing in laryngotracheal stenosis.

Hall SR, Allen CT, Merati AL, Mayerhoff RM.

Laryngoscope. 2017 Jun;127(6):1408-1412. doi: 10.1002/lary.26385. Epub 2016 Nov 12.

PMID:
27861923
22.

Avoiding phagocytosis-related artifact in myeloid derived suppressor cell T-lymphocyte suppression assays.

Davis RJ, Silvin C, Allen CT.

J Immunol Methods. 2017 Jan;440:12-18. doi: 10.1016/j.jim.2016.11.006. Epub 2016 Nov 14.

23.

A Global Exploratory Analysis of Men Participating in Gender-Based Violence Prevention.

Tolman RM, Casey EA, Allen CT, Carlson J, Leek C, Storer HL.

J Interpers Violence. 2019 Aug;34(16):3438-3465. doi: 10.1177/0886260516670181. Epub 2016 Sep 28.

PMID:
27677951
24.

Office-Based vs Traditional Operating Room Management of Recurrent Respiratory Papillomatosis: Impact of Patient Characteristics and Disease Severity.

Tatar EÇ, Kupfer RA, Barry JY, Allen CT, Merati AL.

JAMA Otolaryngol Head Neck Surg. 2017 Jan 1;143(1):55-59. doi: 10.1001/jamaoto.2016.2724.

PMID:
27658005
25.

Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.

Davis RJ, Van Waes C, Allen CT.

Oral Oncol. 2016 Jul;58:59-70. doi: 10.1016/j.oraloncology.2016.05.002. Epub 2016 May 20. Review.

26.

Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers.

Moore EC, Cash HA, Caruso AM, Uppaluri R, Hodge JW, Van Waes C, Allen CT.

Cancer Immunol Res. 2016 Jul;4(7):611-20. doi: 10.1158/2326-6066.CIR-15-0252. Epub 2016 Apr 13.

27.

Pools of programmed death-ligand within the oral cavity tumor microenvironment: Variable alteration by targeted therapies.

Shah S, Caruso A, Cash H, Waes CV, Allen CT.

Head Neck. 2016 Aug;38(8):1176-86. doi: 10.1002/hed.24269. Epub 2016 Apr 9.

28.

Anatomic Derkay Score Is Associated with Voice Handicap in Laryngeal Papillomatosis in Adults.

Kupfer RA, Çadalli Tatar E, Barry JO, Allen CT, Merati AL.

Otolaryngol Head Neck Surg. 2016 Apr;154(4):689-92. doi: 10.1177/0194599816628871. Epub 2016 Feb 23.

PMID:
26908550
29.

Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches.

Allen CT, Clavijo PE, Van Waes C, Chen Z.

Cancers (Basel). 2015 Dec 9;7(4):2397-414. doi: 10.3390/cancers7040900. Review.

30.
31.

Immunohistochemical analysis of NF-κB in human tumor tissue.

Allen CT, Van Waes C.

Methods Mol Biol. 2015;1280:459-68. doi: 10.1007/978-1-4939-2422-6_28.

PMID:
25736767
32.

CCR 20th anniversary commentary: Preclinical study of proteasome inhibitor bortezomib in head and neck cancer.

Allen CT, Conley B, Sunwoo JB, Van Waes C.

Clin Cancer Res. 2015 Mar 1;21(5):942-3. doi: 10.1158/1078-0432.CCR-14-2550.

33.

A Comparison of the Structural Factors of the Propensity for Abusiveness Scale for Women and Men in a Domestic Violence Treatment Program.

Allen CT, Swan SC, Maas CD, Barber S.

J Interpers Violence. 2015 Aug;30(13):2326-43. doi: 10.1177/0886260514552450. Epub 2014 Oct 9.

PMID:
25304668
34.

Hoarseness after metastatic colon cancer treatment.

Caruso AM, Meyer TK, Allen CT.

JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):881-2. doi: 10.1001/jamaoto.2014.1766. No abstract available.

PMID:
25144305
35.

Risk stratification in endoscopic airway surgery: is inpatient observation necessary?

Allen CT, Lee CJ, Meyer TK, Hillel AD, Merati AL.

Am J Otolaryngol. 2014 Nov-Dec;35(6):747-52. doi: 10.1016/j.amjoto.2014.06.014. Epub 2014 Jul 10.

PMID:
25097181
36.

Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.

Wu D, Allen CT, Fromm JR.

Cytometry B Clin Cytom. 2015 Jan;88(1):58-63. doi: 10.1002/cyto.b.21178. Epub 2014 Jul 11.

37.

Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.

Wu D, Allen CT, Fromm JR.

Cytometry B Clin Cytom. 2014 Jun 28. doi: 10.1002/cytob.21178. [Epub ahead of print]

38.

Endoscopic keel placement to treat and prevent anterior glottic webs.

Paniello RC, Desai SC, Allen CT, Khosla SM.

Ann Otol Rhinol Laryngol. 2013 Nov;122(11):672-8.

PMID:
24358626
39.

Measuring bystander attitudes and behavior to prevent sexual violence.

McMahon S, Allen CT, Postmus JL, McMahon SM, Peterson NA, Lowe Hoffman M.

J Am Coll Health. 2014;62(1):58-66. doi: 10.1080/07448481.2013.849258.

PMID:
24313697
40.

Clinical assessment and treatment of the dysfunctional larynx after radiation.

Allen CT, Lee CJ, Merati AL.

Otolaryngol Head Neck Surg. 2013 Dec;149(6):830-9. doi: 10.1177/0194599813503802. Epub 2013 Sep 6. Review.

PMID:
24013140
41.

Prevalence of diabetes mellitus and its impact on disease severity in adult recurrent respiratory papillomatosis.

Lee CJ, Allen CT, Merati AL.

Otolaryngol Head Neck Surg. 2013 Oct;149(4):603-7. doi: 10.1177/0194599813496969. Epub 2013 Jul 12.

PMID:
23851281
42.

Oral hairy leukoplakia in an HIV-negative patient.

Graboyes EM, Allen CT, Chernock RD, Diaz JA.

Ear Nose Throat J. 2013 Jun;92(6):E12.

PMID:
23780596
43.

Emerging insights into head and neck cancer metastasis.

Allen CT, Law JH, Dunn GP, Uppaluri R.

Head Neck. 2013 Nov;35(11):1669-78. doi: 10.1002/hed.23202. Epub 2012 Dec 22. Review.

PMID:
23280716
44.

The influence of participation, gender and organizational sense of community on psychological empowerment: the moderating effects of income.

Speer PW, Peterson NA, Armstead TL, Allen CT.

Am J Community Psychol. 2013 Mar;51(1-2):103-13. doi: 10.1007/s10464-012-9547-1.

PMID:
22847224
45.

Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer.

Judd NP, Allen CT, Winkler AE, Uppaluri R.

Otolaryngol Head Neck Surg. 2012 Sep;147(3):493-500. doi: 10.1177/0194599812442037. Epub 2012 Mar 19.

46.

The clinical implications of antitumor immunity in head and neck cancer.

Allen CT, Judd NP, Bui JD, Uppaluri R.

Laryngoscope. 2012 Jan;122(1):144-57. doi: 10.1002/lary.21913. Review.

PMID:
22183634
47.

TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.

Lu H, Yang X, Duggal P, Allen CT, Yan B, Cohen J, Nottingham L, Romano RA, Sinha S, King KE, Weinberg WC, Chen Z, Van Waes C.

Cancer Res. 2011 Nov 1;71(21):6867-77. doi: 10.1158/0008-5472.CAN-11-2460. Epub 2011 Sep 20.

48.

Why I Hit Him: Women's Reasons for Intimate Partner Violence.

Caldwell JE, Swan SC, Allen CT, Sullivan TP, Snow DL.

J Aggress Maltreat Trauma. 2009 Oct;18(7):672-697.

49.

A model for long-distance dispersal of boll weevils (Coleoptera: Curculionidae).

Westbrook JK, Eyster RS, Allen CT.

Int J Biometeorol. 2011 Jul;55(4):585-93. doi: 10.1007/s00484-010-0359-4. Epub 2010 Sep 11.

PMID:
20835731
50.

Human papillomavirus and oropharynx cancer: biology, detection and clinical implications.

Allen CT, Lewis JS Jr, El-Mofty SK, Haughey BH, Nussenbaum B.

Laryngoscope. 2010 Sep;120(9):1756-72. doi: 10.1002/lary.20936. Review.

PMID:
20669304

Supplemental Content

Loading ...
Support Center